Browsing Centre for Clinical Pharmacology by Subject "bivalirudin"

Now showing items 1-1 of 1

    • Bivalirudin versus heparin in primary PCI: clinical outcomes and cost analysis. 

      Deharo, P; Johnson, TW; Rahbi, H; Kandan, R; Bowles, R; Mozid, A; Dorman, S; Strange, JW; Baumbach, A (2018)
      Background: The evidence for benefits of bivalirudin over heparin has recently been challenged. We aimed to analyse the safety and cost-effectiveness following reintroduction of heparin instead of bivalirudin as the standard ...